wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33710179-2161DF09-CD66-48E8-816B-BEF6B7B2B6AA
Q33710179-2161DF09-CD66-48E8-816B-BEF6B7B2B6AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-2161DF09-CD66-48E8-816B-BEF6B7B2B6AA
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
P2860
Q33710179-2161DF09-CD66-48E8-816B-BEF6B7B2B6AA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33710179-2161DF09-CD66-48E8-816B-BEF6B7B2B6AA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4acd416fd0cce0c7ac4f7f3137e609c9ec023658
P2860
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.